Health-care company stocks rose Wednesday as trade tensions were partially offset by stronger-than-expected services PMI numbers in the U.S.
Jazz Pharmaceuticals' $935 million deal to buy Chimerix could be the start of deal-making by the biopharma, Piper Sandler's David Amsellem and Alex von Riesemann said.
Moderna shares rose sharply after a German court in Duesseldorf ruled that Pfizer and partner BioNTech broke a coronavirus vaccine patent held by Moderna, Reuters reported.
Write to Paulo Trevisani at paulo.trevisani@wsj.com
(END) Dow Jones Newswires
March 05, 2025 17:17 ET (22:17 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.